Construct: ORF ccsbBroadEn_03690
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF015337.1_s300c1, BRDN0000388946
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- BCAP29 (55973)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 55973 | BCAP29 | B cell receptor associated ... | NM_001371353.1 | 100% | 100% | |
| 2 | human | 55973 | BCAP29 | B cell receptor associated ... | NM_001371354.1 | 100% | 100% | |
| 3 | human | 55973 | BCAP29 | B cell receptor associated ... | NM_018844.4 | 100% | 100% | |
| 4 | human | 55973 | BCAP29 | B cell receptor associated ... | NM_001371357.1 | 96.3% | 96.2% | (many diffs) |
| 5 | human | 55973 | BCAP29 | B cell receptor associated ... | NM_001363483.2 | 84.8% | 84.8% | 690_818del |
| 6 | human | 55973 | BCAP29 | B cell receptor associated ... | NM_001371356.1 | 78.8% | 68.9% | (many diffs) |
| 7 | human | 55973 | BCAP29 | B cell receptor associated ... | NM_001363482.1 | 69.6% | 69.1% | (many diffs) |
| 8 | human | 55973 | BCAP29 | B cell receptor associated ... | NM_001371355.1 | 69.6% | 69.1% | (many diffs) |
| 9 | human | 55973 | BCAP29 | B cell receptor associated ... | NM_001008405.4 | 69.2% | 66.6% | 689_767del;803_1044del |
| 10 | human | 115253422 | DUS4L-BCAP29 | DUS4L-BCAP29 readthrough | NM_001371365.2 | 50.1% | 50.1% | 1_720del |
| 11 | human | 115253422 | DUS4L-BCAP29 | DUS4L-BCAP29 readthrough | NM_001371366.2 | 50.1% | 50.1% | 1_720del |
| 12 | human | 115253422 | DUS4L-BCAP29 | DUS4L-BCAP29 readthrough | NM_001371367.2 | 50.1% | 50.1% | 1_720del |
| 13 | human | 115253422 | DUS4L-BCAP29 | DUS4L-BCAP29 readthrough | NM_001371364.2 | 40.9% | 39.4% | 1_720del;1409_1487del;1523_1764del |
| 14 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163926.1 | 27% | (many diffs) | |
| 15 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163929.1 | 24.6% | 1_70del;660_683del;818_2935del | |
| 16 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163934.1 | 23.8% | 1_70del;550_668del;913_3030del | |
| 17 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_027830.2 | 23.2% | (many diffs) | |
| 18 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163927.1 | 22.7% | (many diffs) | |
| 19 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163928.1 | 22.3% | (many diffs) | |
| 20 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163937.1 | 22.2% | (many diffs) | |
| 21 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163933.1 | 22.1% | (many diffs) | |
| 22 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163936.1 | 21% | 1_70del;549_550ins109;685_2802del | |
| 23 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163935.1 | 20.7% | 1_70del;415_983del;1363_3480del | |
| 24 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163931.1 | 20.1% | 1_70del;414_415ins136;658_2775del | |
| 25 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163938.1 | 19.6% | 1_70del;263_264ins151;643_2760del | |
| 26 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163932.1 | 18.4% | (many diffs) | |
| 27 | human | 55973 | BCAP29 | B cell receptor associated ... | NR_163930.1 | 16.7% | (many diffs) | |
| 28 | human | 115253422 | DUS4L-BCAP29 | DUS4L-BCAP29 readthrough | NR_163941.2 | 10.9% | 1_951del;1675_6631del | |
| 29 | human | 115253422 | DUS4L-BCAP29 | DUS4L-BCAP29 readthrough | NR_163940.2 | 10.7% | 1_989del;1678_1756del;1792_6748del | |
| 30 | human | 115253422 | DUS4L-BCAP29 | DUS4L-BCAP29 readthrough | NR_163939.2 | 10.6% | 1_1131del;1855_6811del |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 66
- ORF end:
- 789
- ORF length:
- 723
- Sequence:
-
1 gttcgttgca acaaattgat gagcaatgct tttttataat gccaaCTTTG TACAAAAAAG 61 TTGGCATGAC ACTCCAATGG GCTGCAGTGG CAACCTTTCT TTATGCCGAA ATAGGACTCA 121 TTTTAATCTT CTGCCTACCT TTTATTCCTC CTCAGAGATG GCAGAAGATT TTTTCATTTA 181 ATGTCTGGGG TAAAATTGCA ACTTTTTGGA ACAAGGCTTT CCTTACCATT ATCATCCTAT 241 TGATTGTTCT ATTTCTAGAT GCTGTGAGAG AAGTAAGGAA ATATTCCTCA GTTCATACCA 301 TTGAGAAGAG CTCCACCAGC AGACCTGATG CCTATGAACA CACACAGATG AAACTTTTTA 361 GGTCTCAAAG AAATCTTTAC ATTTCTGGAT TTTCCCTATT TTTTTGGCTA GTTTTGAGAC 421 GTCTGGTTAC GCTTATTACT CAACTGGCAA AAGAACTGTC AAACAAAGGT GTACTTAAAA 481 CTCAAGCAGA AAATACTAAC AAGGCTGCCA AAAAATTTAT GGAAGAAAAC GAAAAACTAA 541 AAAGGATTTT GAAAAGCCAT GGTAAAGATG AAGAATGTGT TTTGGAAGCA GAAAATAAAA 601 AACTAGTAGA AGACCAGGAG AAACTGAAAA CTGAATTAAG GAAGACTTCA GATGCCCTTT 661 CTAAGGCACA AAATGATGTG ATGGAAATGA AGATGCAGTC AGAGAGACTT TCGAAAGAAT 721 ATGATCAACT CCTGAAAGAA CACTCTGAAC TTCAGGATCG TTTAGAAAGA GGCAACAAGA 781 AAAGACTGTG CCCAACTTTC TTGTACAAAG Ttggcattat aagaaagcat tgcttatcaa 841 tttgttgcaa cgaac